Adenosine in myocardial protection in on-pump and off-pump cardiac surgery.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Thoracic Surgery

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0003-4975(02)04694-5PMID 12607714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ischemic Preconditioning in Cardiac Surgery

  2003cited by this paper
• Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion.

  2001cited by this paper
• Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.

  2001cited by this paper
• Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion.

  2001cited by this paper
• Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion.

  2001cited by this paper
• Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting.

  2001cited by this paper
• Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?

  2000cited by this paper
• Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction.

  2000cited by this paper
• Comparison of AMP579 and adenosine in inhibition of cell–cell interaction between human neutrophil and vascular endothelial cell

  2000cited by this paper
• Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion.

  2000cited by this paper
• Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioning

  2000cited by this paper
• Anti-Stunning and Anti-Infarct Effects of Adenosine-Enhanced Ischemic Preconditioning

  2000cited by this paper
• Perfusion-assisted direct coronary artery bypass: selective graft perfusion in off-pump cases.

  2000cited by this paper
• A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium.

  2000cited by this paper
• Myocardial Infarction Adenosine as an Adjunct to Thrombolytic Therapy for Acute Myocardial Infarction

  1999cited by this paper
• Adenosine-supplemented blood cardioplegia attenuates postischemic dysfunction after severe regional ischemia.

  1999cited by this paper
• Optimal Myocardial Preconditioning in Humans a

  1999cited by this paper
• Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

  1998cited by this paper
• Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart.

  1998cited by this paper
• Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.

  1998cited by this paper
• Preconditioning of human myocardium with adenosine during coronary angioplasty.

  1997cited by this paper
• Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.

  1997cited by this paper
• Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery.

  1997cited by this paper
• Phase 1 human trial of adenosine-potassium cardioplegia.

  1996cited by this paper
• Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.

  1996cited by this paper
• Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium.

  1996cited by this paper
• Adenosine reduces postbypass transfusion requirements in humans after heart surgery.

  1996cited by this paper
• Ischemic preconditioning in cardiac surgery: a word of caution.

  1996cited by this paper
• Cardioprotection by adenosine: is it a question of effective dose, timing, or the target compartment?

  1996cited by this paper
• Pretreatment of Human Myocardium with Adenosine During Open Heart Surgery

  1995cited by this paper
• Salutary effects of exogenous adenosine administration on in vivo myocardial stunning.

  1995cited by this paper
• Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts.

  1994cited by this paper
• A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.

  1994cited by this paper
• Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.

  1993cited by this paper
• The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury.

  1992cited by this paper
• Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism.

  1992cited by this paper
• Myocardial Protective Effects of Adenosine: Infarct Size Reduction With Pretreatment and Continued Receptor Stimulation During Ischemia

  1992cited by this paper
• Neutrophil and endothelial changes in reperfusion injury.

  1991cited by this paper
• Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.

  1991cited by this paper
• Neutrophil Accumulation in Ischemic Canine Myocardium: Insights Into Time Course, Distribution, and Mechanism of Localization During Early Reperfusion

  1991cited by this paper
• Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.

  1990cited by this paper
• Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction. Mechanism and physiological implications.

  1990cited by this paper
• Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart.

  1990cited by this paper
• The role of the neutrophil and free radicals in ischemic myocardial injury.

  1989cited by this paper
• Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.

  1989cited by this paper
• Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion.

  1988cited by this paper
• Human Inflammatory Disease. Clinical Immunology

  1988cited by this paper
• Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.

  1987cited by this paper
• Adenosine: a physiological modulator of superoxide anion generation by human neutrophils

  1983cited by this paper
• Adenosine in the local regulation of blood flow: a brief overview.

  1983cited by this paper
• Cellular Protection during Myocardial Ischemia The Development and Characterization of a Procedure for the

  1976cited by this paper
• The Action of Adenosine Upon the Human Heart

  1930cited by this paper
• The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart 1

  1929cited by this paper

• Molecular Mechanisms of Cell Protection Against Injury—The Foundation of Cell Protective Engineering

  2025cites this paper
• Protective Biology and Engineering

  2023cites this paper
• PDRN-Activated A2A-Receptor Reduces NeuronalDamage, Stimulates WNT/β-CATENIN-Driven-Neurogenesis in Spinal-Cord-Injury

  2020cites this paper
• Adenosine as cardioprotective in off-pump coronary artery bypass grafting

  2019cites this paper
• Activation of A2A Receptor by PDRN Reduces Neuronal Damage and Stimulates WNT/β-CATENIN Driven Neurogenesis in Spinal Cord Injury

  2018cites this paper
• Warm (32 degrees celcius) polarised arrest: towards a new cardioprotective strategy using normokalaemic adenosine-lignocaine cardioplegia

  2016cites this paper
• Comparing the endo-aortic balloon and the external aortic clamp in minimally invasive mitral valve surgery.

  2015cites this paper
• An Fc Domain Protein–Small Molecule Conjugate as an Enhanced Immunomodulator

  2014cites this paper
• Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?

  2013cites this paper
• Avaliação da resposta clínica, inflamatória e infecciosa de crianças submetidas à cirurgia de coarctação da aorta com ou sem uso de precondicionamento isquêmico por pinçamento da aorta torácica descendente

  2013cites this paper
• "Polarizing" microplegia improves cardiac cycle efficiency after CABG for unstable angina.

  2013cites this paper
• Targeting adenosine receptors in the development of cardiovascular therapeutics

  2012cites this paper
• Development of a non-depolarising normakalaemic cardioprotective preservation solution for use in orthotopic heart transplantation

  2012cites this paper
• Adenosine in cold blood cardioplegia--a placebo-controlled study.

  2012cites this paper
• Preliminary results of supra-hepatic intraaortic perfusion with nitroglycerin for patients with significant hepatic dysfunction.

  2012cites this paper
• Novel trends in the treatment of cardiovascular disorders: site- and event- selective adenosinergic drugs.

  2011cites this paper
• Adenosine Triphosphate–Sensitive Potassium Channels, Adenosine, and Preconditioning

  2011cites this paper
• 8A. Inflammatory Lung Injury After Cardiopulmonary Bypass is Attenuated by Adenosine A2A Receptor Activation

  2009cites this paper
• Purines and oxypurines in myocardial ischemia.

  2009cites this paper
• Effects of n-acetylcysteine on ischemic preconditioning: study in isolated rat hearts.

  2009influential citation
• Drugs mediating myocardial protection

  2009cites this paper
• Effects of n-acetylcysteine on ischemic preconditioning: study in isolated rat hearts.

  2009influential citation
• Excellent outcomes in a case of complex re-do surgery requiring prolonged cardioplegia using a new cardioprotective approach: adenocaine.

  2008cites this paper
• Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate

  2008cites this paper
• Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation.

  2008cites this paper
• Myocardial Protection from Ischemia and Reperfusion Injury

  2008cites this paper
• Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.

  2007cites this paper
• Adenosine enhances cytosolic phosphorylation potential and ventricular contractility in stunned guinea pig heart: receptor-mediated and metabolic protection.

  2007cites this paper
• Stunning, Hibernation, Preconditioning, Postconditioning and the Effects of Anesthetic Drugs

  2007cites this paper
• A review of the clinical use of anti-inflammatory therapies for reperfusion injury in myocardial infarction and stroke: where do we go from here?

  2006cites this paper
• Synergistic Effects of Atorvastatin and Sildenafil in Cardioprotection—Role of NO

  2006cites this paper
• Preoperative white blood cell count is independently associated with higher perioperative cardiac enzyme release and increased 1-year mortality after coronary artery bypass grafting.

  2006cites this paper
• A comparison of adenosine A2A agonism and methylprednisolone in attenuating neuronal damage and improving functional outcome after experimental traumatic spinal cord injury in rabbits.

  2006cites this paper
• Ischemic preconditioning for the clinician.

  2006cites this paper
• Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway

  2005cites this paper
• Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes.

  2005cites this paper
• Ischaemic preconditioning causes increased myocardial vascular resistance but no myocardial contractility changes in pigs after OPCAB.

  2005cites this paper
• Pharmakologische Präkonditionierung: Adenosin zum Schutz des humanen Myokards während aorto-koronarer Bypassoperationen

  2005cites this paper
• [Myocardial protection in cardiac surgery.].

  2005cites this paper
• Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.

  2005cites this paper
• Proteção miocárdica em cirurgia cardíaca

  2005cites this paper
• Preconditioning and the human heart.

  2005cites this paper
• Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.

  2004cites this paper
• Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages

  2004cites this paper
• Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.

  2004cites this paper
• Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs

  2004cites this paper
• Ischemia, reperfusion, and the role of surgery in the treatment of cardiogenic shock secondary to acute myocardial infarction: an interpretative review.

  2004cites this paper
• Cardiac protection during acute myocardial infarction: where do we stand in 2004?

  2004cites this paper
• Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma.

  2004cites this paper
• Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.

  2004cites this paper
• Thoracic anaesthesia Pro: Fiberoptic bronchoscopy should be partof theDoubleLumenTubesplacement Related review: Double-lumen tube position should be confirmed by fiberoptic bronchoscopy

  2004cites this paper
• Heat stress preconditioning and delayed myocardial protection: what is new?

  2003cites this paper